SGP SpyGlass Pharma, Inc.
Fundamentals / CIK 0001778922 / USDSpyGlass Pharma, Inc. reported $226.3M in total assets and a net loss of $70.49M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SGP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$77.25M Operating profit
-
Net Income FY 2025-$70.49M GAAP bottom line
-
Diluted EPS FY 2025-$2.11 Split-adjusted
-
Free Cash Flow FY 2025-$59.23M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$208.7M Total debt: $1.61M
Annual revenue and net income
2 fiscal years (2024 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 |
|---|---|---|
| Research & Development | $29.18M | $19.98M |
| Total Operating Expenses | $41.45M | $27.06M |
| Operating Income | -$41.45M | -$27.06M |
| EBITDA | -$40.84M | -$26.79M |
| Interest Income | $3.11M | $1.32M |
| Income Before Tax | -$39.87M | -$29.16M |
| Income Tax Expense | $0 | $0 |
| Net Income | -$39.87M | -$29.16M |
| Basic EPS | -$103.10 | -$93.52 |
| Diluted EPS | -$103.10 | -$93.52 |
| Basic Shares Outstanding | 386.7K | 311.9K |
| Diluted Shares Outstanding | 386.7K | 311.9K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Research & Development | $10.03M | $10.94M | $8.54M | $7.71M | $8.09M | $7.33M | $6.05M |
| Total Operating Expenses | $26.25M | $21.97M | $15.41M | $13.63M | $11.10M | $9.30M | $7.42M |
| Operating Income | -$26.25M | -$21.97M | -$15.41M | -$13.63M | -$11.10M | -$9.30M | -$7.42M |
| EBITDA | -$25.96M | -$21.63M | -$15.09M | -$13.41M | -$10.96M | -$9.16M | -$7.30M |
| Interest Income | $1.99M | $2.10M | $1.59M | $1.07M | $1.28M | $622K | $126K |
| Income Before Tax | -$24.25M | -$19.86M | -$13.82M | -$12.55M | -$9.82M | -$8.68M | -$8.82M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$24.25M | -$19.86M | -$13.82M | -$12.55M | -$9.82M | -$8.68M | -$8.82M |
| Basic EPS | -$0.73 | -$0.59 | -$0.69 | -- | -$4.53 | -$3.81 | -$3.96 |
| Diluted EPS | -$0.73 | -$0.59 | -$0.69 | -- | -$4.53 | -$3.81 | -$3.96 |
| Basic Shares Outstanding | 33.5M | 33.4M | 19.9M | -- | 2.2M | 2.3M | 2.2M |
| Diluted Shares Outstanding | 33.5M | 33.4M | 19.9M | -- | 2.2M | 2.3M | 2.2M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $96.36M | $16.27M |
| Cash & Short-Term Investments | $96.36M | $16.27M |
| Total Current Assets | $108.8M | $17.41M |
| Property, Plant & Equipment, Net | $2.34M | $2.17M |
| Other Non-Current Assets | $492K | $453K |
| Total Non-Current Assets | $7.10M | $5.91M |
| Total Assets | $115.9M | $23.32M |
| Accounts Payable | $2.70M | $1.98M |
| Other Current Liabilities | $3.71M | $672K |
| Total Current Liabilities | $8.58M | $7.79M |
| Total Non-Current Liabilities | $1.58M | $3.46M |
| Total Liabilities | $10.17M | $11.25M |
| Total Debt (incl. Leases) | $1.57M | $3.90M |
| Common Stock | $0 | $0 |
| Retained Earnings | -$104.7M | -$64.86M |
| Total Stockholders' Equity | -$98.84M | -$60.47M |
| Total Equity | -$98.84M | -$60.47M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $208.7M | $223.1M | $238.9M | $96.36M | $16.27M |
| Cash & Short-Term Investments | $208.7M | $223.1M | $238.9M | $96.36M | $16.27M |
| Total Current Assets | $217.9M | $236.5M | $253.4M | $108.8M | $17.41M |
| Property, Plant & Equipment, Net | $6.34M | $4.79M | $2.75M | $2.34M | $2.17M |
| Other Non-Current Assets | $689K | $759K | $789K | $492K | $453K |
| Total Non-Current Assets | $8.43M | $6.97M | $5.02M | $7.10M | $5.91M |
| Total Assets | $226.3M | $243.4M | $258.4M | $115.9M | $23.32M |
| Accounts Payable | $5.65M | $4.16M | $3.51M | $2.70M | $1.98M |
| Other Current Liabilities | $6.14M | $3.56M | $2.27M | $3.71M | $672K |
| Total Current Liabilities | $14.30M | $9.44M | $6.67M | $8.58M | $7.79M |
| Total Non-Current Liabilities | $1.61M | $1.63M | $1.61M | $1.58M | $3.46M |
| Total Liabilities | $15.91M | $11.07M | $8.27M | $10.17M | $11.25M |
| Total Debt (incl. Leases) | $1.61M | $1.63M | $1.61M | $1.57M | $3.90M |
| Common Stock | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$162.7M | -$138.4M | -$118.5M | -$104.7M | -$64.86M |
| Total Stockholders' Equity | $210.4M | $232.4M | $250.1M | -$98.84M | -$60.47M |
| Total Equity | $210.4M | $232.4M | $250.1M | -$98.84M | -$60.47M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 |
|---|---|---|
| Net Income | -$39.87M | -$29.16M |
| Depreciation & Amortization | $612K | $271K |
| Stock-Based Compensation | $2.79M | $1.49M |
| Change in Payables | $549K | $1.34M |
| Operating Cash Flow | -$32.70M | -$22.03M |
| Capital Expenditure | -$789K | -$1.99M |
| Free Cash Flow | -$33.49M | -$24.02M |
| Investing Cash Flow | -$11.79M | $22.26M |
| Share Repurchases | -$1.45M | $0 |
| Financing Cash Flow | $124.6M | $185K |
| Net Change in Cash | $80.09M | $419K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$24.25M | -$19.86M | -$13.82M | -$12.55M | -$9.82M | -$8.68M | -$8.82M |
| Depreciation & Amortization | $280K | $341K | $318K | $217K | $137K | $135K | $124K |
| Stock-Based Compensation | $2.31M | $2.08M | $1.68M | $922K | $932K | $587K | $345K |
| Change in Payables | $1.51M | $764K | $953K | $1.02M | -$1.29M | $1.19M | -$372K |
| Operating Cash Flow | -$16.02M | -$14.84M | -$13.54M | -$9.34M | -$8.84M | -$6.33M | -$8.20M |
| Capital Expenditure | -$2.46M | -$1.93M | -$676K | -$421K | -$152K | -$52K | -$164K |
| Free Cash Flow | -$18.48M | -$16.77M | -$14.22M | -$9.76M | -$8.99M | -$6.38M | -$8.37M |
| Investing Cash Flow | $1.54M | -$933K | -$1.67M | $574K | -$12.15M | -$52K | -$164K |
| Financing Cash Flow | $27K | $13K | $157.8M | -$888K | -$236K | $75.61M | $50.10M |
| Net Change in Cash | -$14.46M | -$15.76M | $142.5M | -$9.65M | -$21.23M | $69.24M | $41.73M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 |
|---|---|---|
| Return on Assets (ROA) | -34.4% | -125.1% |
| Current Ratio | 12.67x | 2.23x |
| Quick Ratio | 11.23x | 2.09x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -33.5% | -24.1% | -17.9% | -- | -- | -- | -- |
| Return on Assets (ROA) | -31.1% | -23.0% | -17.4% | -34.4% | -- | -- | -- |
| Current Ratio | 15.24x | 25.06x | 38.00x | 12.67x | -- | -- | -- |
| Quick Ratio | 14.60x | 23.65x | 35.83x | 11.23x | -- | -- | -- |
| Debt to Equity | 0.01x | 0.01x | 0.01x | -- | -- | -- | -- |